EPITHELIOID MESOTHELIOMA
Clinical trials for EPITHELIOID MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new EPITHELIOID MESOTHELIOMA trials appear
Sign up with your email to follow new studies for EPITHELIOID MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to boost mesothelioma surgery success
Disease control OngoingThis early-phase trial is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy (cisplatin and pemetrexed) before and after surgery can help people with resectable pleural mesothelioma. The study includes 28 participants with stage I-III disease. The…
Matched conditions: EPITHELIOID MESOTHELIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a Triple-Drug combo tame mesothelioma?
Disease control OngoingThis study tests whether adding the drug cediranib to standard chemotherapy (cisplatin and pemetrexed) can help people with malignant pleural mesothelioma, a rare and aggressive lung cancer. In the first phase, researchers found the safest dose of cediranib. In the second phase, …
Matched conditions: EPITHELIOID MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC